We are proud to announce that NUVIA and Cyclomedical International, Inc. International have entered into a strategic alliance aimed at further developing services in the field of radiopharmaceutical production facilities, combining complementary expertise for startup and operation of cyclotron facilities and radiopharmacies.
The Nuclear Medicine market’s shift toward precision medicine requires that the existing network of production facilities be extended and production of critical drugs managed by medical institutions directly, for the benefit of patients. NUVIA and Cyclomedical are exploring how to put their respective competences to action in this endeavor.
Cyclomedical International was formed in 2002 to extend production of PET biomarkers in the US.
